UD CIAN 300
Each sustained release uncoated tablet contains: Ursodeoxycholic acid IP 300 mg Excipients q.s.
UD CIAN 300
| Composition | Each sustained release uncoated tablet contains: Ursodeoxycholic acid IP 300 mg Excipients q.s. |
| Packing | ALU ALU - 10*1*10 |
| MRP | ₹410.00000 |
| Manufacturer | CIAN HEALTHCARE LTD |
| HSN Code | 30049036.0 |
Product image not available
PCD Franchise Opportunity
Request This Product
Get bulk pricing, MOQ, and franchise availability for UD CIAN 300.
Related Products
More products in the HEPATO PROTECTIVE therapeutic category
ORICIAN P
Each enteric coated tablet contains: L-Ornithine-L-Aspartate 150 mg Pancreatin I.P. 100 mg Excipients q.s.
BLISTER CLEAR PVC - 10*10
PANCIAN
Each Hard gelatin capsule contains : Pancreatin IP 300 mg (as enteric coated pellets) equivalent to Lipase Activity 25,000 Ph Eur Units Amylase Activity 20,000 Ph Eur Units Protease Activity 1,000 Ph Eur Units
ALU ALU - 10*10
UD Cian
Each film coated tablet contains: Ursodeoxycholic acid BP 150 mg Excipients q.s
BLISTER CLEAR PVC - 10*10
Interested in this product?
Contact our team to discuss PCD franchise, bulk orders, or contract manufacturing for your market.